Home / Tag Archives: Type 2 Diabetes

Tag Archives: Type 2 Diabetes

Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”

Resistant starch foods including oats, legumes, bananas, and whole grains illustrating the second-meal effect on blood sugar.

Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …

Read More »

Frozen Shoulder and Diabetes: The Overlooked Complication That Can Steal Mobility

Woman with diabetes experiencing shoulder pain from diabetic shoulder adhesive capsulitis, also known as frozen shoulder.

Diabetes complications are often discussed in terms of the heart, kidneys, eyes, and nerves. However, diabetes can also affect joints and connective tissue. Adhesive capsulitis, or frozen shoulder, is one diabetes-related complication that deserves more attention. It can begin with ordinary shoulder pain and gradually make simple movements surprisingly difficult. …

Read More »

Low Potassium, Higher Diabetes Risk? A Surprising Clue From Heart Failure Research

Low potassium and diabetes risk illustrated with a glucose meter, potassium-rich foods, heart model, and pancreas.

Low potassium is usually viewed through a cardiovascular lens, especially in patients with heart failure. However, emerging evidence suggests clinicians may have another reason to pay attention. New research examining the relationship between hypokalemia and diabetes risk found that lower serum potassium levels were associated with a greater risk of …

Read More »

Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?

Blood sample illustrating epigenetic cardiovascular risk prediction using DNA methylation to assess heart risk in type 2 diabetes.

Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …

Read More »

GLP-1s and Opioids: The GI Risk Clinicians May Be Missing

GLP-1 medications and opioid therapy representing potential gastrointestinal risks from concurrent treatment.

GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …

Read More »

Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?

Patient with Type 2 diabetes using real-time CGM while receiving maintenance hemodialysis.

Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …

Read More »

A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?

Clinician reviewing A1C and glycated albumin results for type 2 diabetes monitoring

A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …

Read More »